Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

NCT01604772 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01604772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
July 23, 2012
Completion date
November 22, 2014
Enrollment
16 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent oral cavity adenoid cystic carcinoma, recurrent salivary gland carcinoma, salivary gland adenoid cystic carcinoma, stage iva major salivary gland cancer ajcc v7, stage iva oral cavity adenoid cystic carcinoma ajcc v6 and v7, stage ivb major salivary gland cancer ajcc v7, stage ivb oral cavity adenoid cystic carcinoma ajcc v6 and v7, stage ivc major salivary gland cancer ajcc v7, stage ivc oral cavity adenoid cystic carcinoma ajcc v6 and v7